Diplomat Announces 1st Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Diplomat Pharmacy (DPLO) PT Raised to $17 at Cowen; Reiterates Market Perform
May 9, 2017 8:11 AM EDTCowen raised its price target on Diplomat Pharmacy (NYSE: DPLO) to $17.00 (from $12.00) while maintaining a Market Perform rating. DPLO reported 1Q revenues of $1.08B, which was in-line with consensus, due to acquisitions, manufacturing price increases and contributions from new drugs. Adjusted EPS of $0.19 also exceeded... More
Diplomat Pharmacy (DPLO) Tops Q1 EPS by 4c, Offers FY Guidance
May 8, 2017 4:22 PM EDTDiplomat Pharmacy (NYSE: DPLO) reported Q1 EPS of $0.19, $0.04 better than the analyst estimate of $0.15. Revenue for the quarter came in at $1.08 billion versus the consensus estimate of $1.08 billion.
GUIDANCE:
Diplomat Pharmacy sees FY2017 EPS of $0.54-$0.74, versus the consensus of... More
